Practical issues in medication compliance in hypertensive patients

References

• Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology. J Hypertens. 2007;25: 1105–1187.
   PubMed Web of Science ®Google Scholar
• Chobanian AV Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;289:2560–2572.
   PubMed Web of Science ®Google Scholar
• Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment and control of hypertension, 1998–2008. JAMA. 2010;303: 2043–2050.
   PubMed Web of Science ®Google Scholar
• Ho PM, Magid DJ, Shetterly SM, et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med. 2008;168:271–276.
   PubMed Web of Science ®Google Scholar
• Elliott WL. Improving outcomes in hypertensive patients: Focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens. 2009;11:376–382.
   PubMed Web of Science ®Google Scholar
• Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19: 1190–1196.
   PubMed Web of Science ®Google Scholar
• Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: Its importance in cardiovascular outcomes. Circulation. 2009;119:3028–3035.
   PubMed Web of Science ®Google Scholar
• Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories. BMJ. 2008;336:1114–1117.
   PubMed Web of Science ®Google Scholar
• Lowry KP, Dudley TK, Oddone EZ, Bosworth HB. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother. 2005;39:1198–1203.
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. New Engl J Med. 2005;353:487–497.
   PubMed Web of Science ®Google Scholar
• Mulazzi I, Cambou JP, Girerd X, Nicodeme R, Chamontin B, Amar J. Six-item self-administered questionnaires in the waiting room: An aid to explain uncontrolled hypertension in high-risk patients seen in general practice. J Am Soc Hypertens. 2009;3:221–227.
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive value of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10:348–354.
   PubMed Web of Science ®Google Scholar
• Halpern MT, Khan ZM, Schmier JK, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension. 2006;47:1039–1048.
   PubMed Web of Science ®Google Scholar
• Fung V Huang J, Brand R, Newhouse JP, Hsu J. Hypertension treatment in a Medicare population: Adherence and systolic blood pressure control. Clin Ther. 2007;29:972–984.
   PubMed Web of Science ®Google Scholar
• Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120:1598–1605.
   PubMed Web of Science ®Google Scholar
• Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens. 2005;23:2101–2107.
   PubMed Web of Science ®Google Scholar
• Choudhry NK, Fischer MA, Avorn J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011;171: 814–822.
   PubMed Web of Science ®Google Scholar
• Patel BV Remigio-Baker RA, Mehta D, Thiebaud P, Frech-Tamas F, Preblick R. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States. J Clin Hypertens. 2007;9:692–700.
   PubMedGoogle Scholar
• Kronish IM, Woodward M, Sergie Z, Ogedegbe G, Falzon L, Mann DM. Meta-analysis: Impact of drug class on adherence to antihypertensives. Circulation. 2011;123:1611–1621.
   PubMed Web of Science ®Google Scholar
• Duru OK, Vargas RB, Kermah D, Pan D, Norris KC. Health insurance status and hypertension monitoring and control in the United States. Am J Hypertens. 2007;20:348–353.
   Web of Science ®Google Scholar
• Bautista LE. Predictors of persistence with antihypertensive therapy: Results from the NHANES. Am J Hypertens. 2008;21: 182–188.
   Web of Science ®Google Scholar
• Kettani FZ, Dragomir A, Côté R, et al. Impact of better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke. 2009;40:213–220.
   PubMed Web of Science ®Google Scholar
• Corrao G, Parodi A, Nicotra F, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011 ;29: 610–618.
   Google Scholar
• Wetzels GEC, Nelemans P, Schouten JS, Prins MH. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: A systematic review. J Hypertens. 2004;22:1849–1855.
   PubMed Web of Science ®Google Scholar
• Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15–20.
   PubMed Web of Science ®Google Scholar
• Granger BB, Swedberg K, Ekman I, et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: Double-blind, randomised, controlled trial. Lancet. 2005;366:2005–2011.
   PubMed Web of Science ®Google Scholar
• Gallup G Jr, Cotugno HE. Preferences and practices of Americans and their physicians in antihypertensive therapy. Am J Med. 1986; 81 Suppl 6C:20–24.
   Google Scholar
• Eisen SA, Woodward RS, Miller D, Spitznagel E, Windham CA. The effect of medication compliance on the control of hypertension. J Gen Intern Med. 1987;2:298–305.
   PubMed Web of Science ®Google Scholar
• Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004;164: 722–732.
   PubMed Web of Science ®Google Scholar
• Iskedijan M, Einarson TR, MacKeigan LD, et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis. Clin Ther. 2002;24: 302–316.
   Web of Science ®Google Scholar
• Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther. 1998;20:671–681.
   PubMed Web of Science ®Google Scholar
• Conlin PR, Gerth WC, Fox J, Roehm JB, Boccuzzi SJ. Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes. Clin Ther. 2001;23:1999–2010.
   PubMed Web of Science ®Google Scholar
• Feldman RD, Zou GY, Vandervoort MK, Wong CJ, Nelson SAE, Feagan BG. A simplified approach to the treatment of uncomplicated hypertension. A cluster randomized, controlled trial. Hypertension. 2009;53:646–653.
   PubMed Web of Science ®Google Scholar
• Home R, Clatworthy J, Polmear A, Weinman J. Do hypertensive patients’ beliefs about their illness and treatment influence medication adherence and quality of life? J Hum Hypertens. 2001;15 Suppl 1: S65–S68.
   Google Scholar
• Serumaga B, Ross-Degan D, Avery AJ, et al. Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: Interrupted time series study. BMJ. 2011;342:108.
   PubMed Web of Science ®Google Scholar
• Barclay E. Text messages could hasten tuberculosis drug compliance. Lancet. 2009;373:15–16.
   PubMed Web of Science ®Google Scholar
• Walsh JM, McDonald KM, Shojania KG, et al. Quality improvement strategies for hypertension management: A systematic review. Med Care. 2006;44:646–657.
   PubMed Web of Science ®Google Scholar
• Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169:1996–2002.
   PubMedGoogle Scholar
• Edmonds D, Foerster E, Groth H, Gremminger P, Siegenthaler W, Vetter W. Does self-measurement of blood pressure improve patient compliance in hypertension. J Hypertens.1985;3(Suppl 1): S31-S34.
   Google Scholar
• Ogedegbe G, Schoenthaler A. A systemic review ofthe effects of home blood pressure monitoring on medication adherence J Clin Hypertens. 2006;8:174–180.
   PubMedGoogle Scholar
• Marques-Contreras E, Martell-Claros N, Gil-Guillen V et al. Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: The EAPACUM-HTA study. J Hypertens. 2006;24:169–175.
   Web of Science ®Google Scholar
• McManus RJ, Mant J, Roalfe A, et al. Targets and self monitoring in hypertension: Randomised controlled trial and cost effectiveness analysis. BMJ. 2005;331:493.
   PubMed Web of Science ®Google Scholar
• Jones DW, Peterson Ed. Improving hypertension control rates: Technology, people, or systems? JAMA. 2008;299:2896–2898.
   Web of Science ®Google Scholar
• Parati G, Omboni S. Role of home pressure telemonitoring in hypertension management: An update. Blood Press Monit. 2010; 15(6): 285–295.
   Web of Science ®Google Scholar